Experimental treatment conceived by Josh Cohen '14 might hold promise for slowing progression of ALS and Alzheimers
September 4, 2020
Justin Klee '13 (left) and BME student Joshua Cohen '14 are the co-founders and co-CEOs of Amylyx Pharmaceuticals.
Link to Stat News article: https://www.statnews.com/2020/09/02/experimental-drug-for-als-dreamed-up...